摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-甲基-6-(4-甲基哌嗪-1-基)嘧啶-2-基胺 | 5948-63-0

中文名称
4-甲基-6-(4-甲基哌嗪-1-基)嘧啶-2-基胺
中文别名
——
英文名称
UTSAM550
英文别名
2-Amino-4-methyl-6-(N-methyl-piperazino)-pyrimidin;2-Amino-4-methyl-6-<4-methyl-piperazino>-pyrimidin;4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylamine;4-Methyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-amine
4-甲基-6-(4-甲基哌嗪-1-基)嘧啶-2-基胺化学式
CAS
5948-63-0
化学式
C10H17N5
mdl
——
分子量
207.278
InChiKey
YUSOSBOKYGGFKB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    58.3
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    N-甲基哌嗪2-氨基-4-氯-6-甲基嘧啶三乙胺 作用下, 以 乙醇 为溶剂, 反应 16.0h, 以85%的产率得到4-甲基-6-(4-甲基哌嗪-1-基)嘧啶-2-基胺
    参考文献:
    名称:
    Structure−Activity Studies on a Series of a 2-Aminopyrimidine-Containing Histamine H4 Receptor Ligands
    摘要:
    A series of 2-aminopyrimidines was synthesized as ligands of the histamine H-4 receptor (H4R). Working in part from a pyrimidine hit that was identified in an HTS campaign, SAR studies were carried out to optimize the potency, which led to compound 3,4-tert-butyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylamine. We further studied this compound by systematically modifying the core pyrimidine moiety, the methylpiperazine at position 4, the NH2 at position 2, and positions 5 and 6 of the pyrimidine ring. The pyrimidine 6 position benefited the most from this optimization, especially in analogs in which the 6-tert-butyl was replaced with aromatic and secondary amine moieties. The highlight of the optimization campaign was compound 4, 4-[2-amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]benzonitrile, which was potent in vitro and was active as an anti-inflammatory agent in an animal model and had antinociceptive activity in a pain model, which supports the potential of H4R antagonists in pain.
    DOI:
    10.1021/jm8005959
点击查看最新优质反应信息

文献信息

  • Method for Pain Treatment
    申请人:Cowart Marlon D.
    公开号:US20080194538A1
    公开(公告)日:2008-08-14
    This invention discloses a method of treating pain by administering histamine H 4 receptor ligands and compositions comprising the same.
    这项发明揭示了一种通过给予组织胺H4受体配体和包含相同的组合物来治疗疼痛的方法。
  • 2-Aminopyrimidine modulators of the histamine H4 receptor
    申请人:Cai Hui
    公开号:US20080194577A1
    公开(公告)日:2008-08-14
    2-Aminopyrimidine compounds are described, which are useful as H 4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H 4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
    描述了2-氨基嘧啶化合物,这些化合物可作为H4受体调节剂。这些化合物可用于制药组合物和治疗由H4受体活性介导的疾病状态、疾病和病况的方法,如过敏、哮喘、自身免疫疾病和瘙痒症。
  • 2 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions
    申请人:Raphy Gilles
    公开号:US20100035863A1
    公开(公告)日:2010-02-11
    The present invention concerns novel 2 amino pyrimidine derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use as harmaceuticals.
    本发明涉及式(I)的新型2-氨基嘧啶衍生物,制备它们的过程,含有它们的药物组合物以及它们作为药物的用途。
  • 2-AMINOPYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR
    申请人:Cai Hui
    公开号:US20110218338A1
    公开(公告)日:2011-09-08
    2-Aminopyrimidine compounds are described, which are useful as H 4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H 4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritus.
    本文描述了2-氨基嘧啶化合物,这些化合物可用作H4受体调节剂。这些化合物可用于制备药物组合物和治疗疾病状态、障碍和条件的方法,这些状态、障碍和条件是由H4受体活性介导的,例如过敏、哮喘、自身免疫性疾病和瘙痒症。
  • Dérivés de de la 6-méthyl-pyrimidine-2,4-diamine, procédé de synthèse, compositions les comprenant et utilisations comme agents neutralisants basiques
    申请人:L'OREAL
    公开号:EP1437348A1
    公开(公告)日:2004-07-14
    L'invention se rapporte à de nouveaux dérivés de la famille de la 6-méthyl-pyrimidine-2,4-diamine répondant à la formule (I) suivante : à leur procédé de synthèse, aux compositions cosmétiques ou pharmaceutiques les comprenant, ainsi qu'à leur utilisation comme agents neutralisants basiques ou comme agents conservateurs.
    本发明涉及与下式(I)相对应的 6-甲基嘧啶-2,4-二胺家族的新衍生物: 它们的合成工艺,含有它们的化妆品或药物组合物,以及它们作为碱性中和剂或防腐剂的用途。
查看更多